HEARTCARE-B (06609) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Potential Final Dividend

Bulletin Express

03/16

Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.

The notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).

No additional financial figures or dividend amounts were disclosed in the announcement.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1163117966"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163117966\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163117966?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163117966","market":"hk","top_or_hot":-1,"title":"HEARTCARE-B (06609) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Potential Final Dividend","media":"Bulletin Express","content":"<p>Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.</p>\n<p>The notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).</p>\n<p>No additional financial figures or dividend amounts were disclosed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HEARTCARE-B (06609) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Potential Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHEARTCARE-B (06609) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Potential Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-16 17:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.</p>\n<p>The notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).</p>\n<p>No additional financial figures or dividend amounts were disclosed in the announcement.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06609","symbol_name":"心瑋醫療-B","start_time":0,"source_url":"","article_id":"1163117966","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163117966","pubTimestamp":1773652843,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06609":"心玮医疗-B"},"translate_title":"HEARTCARE-B(06609)定于2026年3月26日召开董事会会议，批准2025财年业绩和潜在末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06609":1},"content_text":"Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.\nThe notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).\nNo additional financial figures or dividend amounts were disclosed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}